Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ferrante

Showing results (151-160 of 162) with videos related to

Pageof 17
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
High-dose chemotherapy for ovarian carcinoma: long-term results from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)J A Ledermann, R Herd, D Maraninchi, et al.
Bone Marrow Transplantation|May 24, 2005
High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)C Bengala, V Guarneri, J Ledermann, et al.
AIDS (London, England)|November 4, 2000
Immune activation in africa is environmentally-driven and is associated with upregulation of CCR5. Italian-Ugandan AIDS ProjectM Clerici, S Butto, M Lukwiya, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 30, 2005
MSRV, Syncytin and the role of endogenous retroviral proteins in demyelinationJ Garson, A Créange, A Dolei, et al.
AIDS (London, England)|March 15, 2000
Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volumeA Vigano, S Vella, M Saresella, et al.
Tumori|April 4, 1998
The use of granulocyte colony-stimulating factors following peripheral blood progenitor cell rescue after high-dose chemotherapy for advanced breast cancer: a prospective studyC Dazzi, L Albertazzi, G Rosti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 1998
Cytokine production and surface marker expression in acute and stable multiple sclerosis: altered IL-12 production and augmented signaling lymphocytic activation molecule (SLAM)-expressing lymphocytes in acute multiple sclerosisP Ferrante, M L Fusi, M Saresella, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 1, 1996
Nucleotide sequence and restriction fragment-length polymorphism analysis of human T-cell lymphotropic virus type II (HTLV-II) in southern Europe: evidence for the HTLV-IIa and HTLV-IIb subtypesA Vallejo, P Ferrante, V Soriano, et al.
Neurology|December 12, 2001
HLA-DRB1*1501 and response to copolymer-1 therapy in relapsing-remitting multiple sclerosisC Fusco, V Andreone, G Coppola, et al.
The Journal of Infectious Diseases|October 7, 2000
Mucosal and systemic immune activation is present in human immunodeficiency virus-exposed seronegative womenM Biasin, S L Caputo, L Speciale, et al.
Pageof 17

Showing results (151-160 of 162) with videos related to

Sort By:
Pageof 17
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
High-dose chemotherapy for ovarian carcinoma: long-term results from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)J A Ledermann, R Herd, D Maraninchi, et al.
Bone Marrow Transplantation|May 24, 2005
High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)C Bengala, V Guarneri, J Ledermann, et al.
AIDS (London, England)|November 4, 2000
Immune activation in africa is environmentally-driven and is associated with upregulation of CCR5. Italian-Ugandan AIDS ProjectM Clerici, S Butto, M Lukwiya, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 30, 2005
MSRV, Syncytin and the role of endogenous retroviral proteins in demyelinationJ Garson, A Créange, A Dolei, et al.
AIDS (London, England)|March 15, 2000
Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volumeA Vigano, S Vella, M Saresella, et al.
Tumori|April 4, 1998
The use of granulocyte colony-stimulating factors following peripheral blood progenitor cell rescue after high-dose chemotherapy for advanced breast cancer: a prospective studyC Dazzi, L Albertazzi, G Rosti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 1998
Cytokine production and surface marker expression in acute and stable multiple sclerosis: altered IL-12 production and augmented signaling lymphocytic activation molecule (SLAM)-expressing lymphocytes in acute multiple sclerosisP Ferrante, M L Fusi, M Saresella, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 1, 1996
Nucleotide sequence and restriction fragment-length polymorphism analysis of human T-cell lymphotropic virus type II (HTLV-II) in southern Europe: evidence for the HTLV-IIa and HTLV-IIb subtypesA Vallejo, P Ferrante, V Soriano, et al.
Neurology|December 12, 2001
HLA-DRB1*1501 and response to copolymer-1 therapy in relapsing-remitting multiple sclerosisC Fusco, V Andreone, G Coppola, et al.
The Journal of Infectious Diseases|October 7, 2000
Mucosal and systemic immune activation is present in human immunodeficiency virus-exposed seronegative womenM Biasin, S L Caputo, L Speciale, et al.
Pageof 17